Shepherd Kaplan Krochuk’s Gilead Sciences GILD Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$884K	Sell	6,343 -93	-1%	-$13K	0.74%	35
2025 Q4	$790K	Sell	6,436 -545	-8%	-$66.2K	0.65%	35
2025 Q3	$775K	Sell	6,981 -571	-8%	-$64.9K	0.64%	38
2025 Q2	$837K	Sell	7,552 -6	-0.1%	-$639	0.73%	33
2025 Q1	$847K	Buy	+7,558	New	+$780K	0.73%	32
2022 Q4	–	Sell	-3,700	Closed	-$228K	–	98
2022 Q3	$228K	Hold	3,700	–	–	0.11%	111
2022 Q2	$229K	Hold	3,700	–	–	0.1%	145
2022 Q1	$220K	Hold	3,700	–	–	0.08%	157
2021 Q4	$269K	Hold	3,700	–	–	0.1%	145
2021 Q3	$258K	Hold	3,700	–	–	0.09%	141
2021 Q2	$255K	Hold	3,700	–	–	0.09%	153
2021 Q1	$239K	Sell	3,700 -300	-8%	-$19.3K	0.09%	153
2020 Q4	$233K	Sell	4,000 -700	-15%	-$42.2K	0.09%	156
2020 Q3	$297K	Sell	4,700 -1,400	-23%	-$97.1K	0.12%	123
2020 Q2	$469K	Buy	6,100 +400	+7%	+$30.7K	0.21%	84
2020 Q1	$426K	Sell	5,700 -8,331	-59%	-$576K	0.69%	47
2019 Q4	$912K	Hold	14,031	–	–	0.69%	45
2019 Q3	$889K	Hold	14,031	–	–	0.65%	44
2019 Q2	$948K	Sell	14,031 -4,969	-26%	-$327K	0.67%	40
2019 Q1	$1.24M	Buy	19,000 +8,400	+79%	+$558K	0.77%	29
2018 Q4	$663K	Hold	10,600	–	–	0.45%	63
2018 Q3	$818K	Hold	10,600	–	–	0.42%	59
2018 Q2	$751K	Hold	10,600	–	–	0.46%	63
2018 Q1	$799K	Sell	10,600 -3,500	-25%	-$278K	0.49%	61
2017 Q4	$1.01M	Sell	14,100 -141	-1%	-$10.7K	0.63%	43
2017 Q3	$1.15M	Sell	14,241 -2,559	-15%	-$196K	0.96%	25
2017 Q2	$1.19M	Buy	16,800 +1,000	+6%	+$66.5K	0.69%	36
2017 Q1	$1.07M	Buy	15,800 +4,903	+45%	+$345K	0.55%	38
2016 Q4	$780K	Buy	10,897 +2,670	+32%	+$198K	0.22%	57
2016 Q3	$651K	Buy	8,227 +541	+7%	+$43.9K	0.14%	97
2016 Q2	$641K	Sell	7,686 -1,276	-14%	-$113K	0.16%	86
2016 Q1	$823K	Buy	8,962 +5,503	+159%	+$496K	0.26%	64
2015 Q4	$350K	Sell	3,459 -7,467	-68%	-$777K	0.09%	165
2015 Q3	$1.07M	Buy	10,926 +203	+2%	+$22.5K	0.29%	59
2015 Q2	$1.25M	Buy	10,723 +1,847	+21%	+$202K	0.24%	77
2015 Q1	$871K	Buy	8,876 +3,114	+54%	+$316K	0.15%	110
2014 Q4	$543K	Sell	5,762 -2,160	-27%	-$223K	0.09%	198
2014 Q3	$844K	Buy	7,922 +3,613	+84%	+$354K	0.11%	152
2014 Q2	$357K	Sell	4,309 -3,533	-45%	-$275K	0.04%	276
2014 Q1	$556K	Buy	7,842 +3,533	+82%	+$277K	0.06%	203
2013 Q4	$324K	Hold	4,309	–	–	0.04%	289
2013 Q3	$271K	Hold	4,309	–	–	0.04%	327
2013 Q2	$221K	Buy	+4,309	New	+$225K	0.04%	398

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Shepherd Kaplan Krochuk's GILD Position: Q1 2026 in Review

Shepherd Kaplan Krochuk reduced its Gilead Sciences (GILD) stake by 1.4% in Q1 2026, selling an estimated $13K and leaving 6,343 shares worth $884K. The position accounts for 0.74% of the portfolio, ranked #35.

Shepherd Kaplan Krochuk first reported a position in GILD in Q2 2013 and has held it in 43 quarters since. The position peaked at $1.25M in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Shepherd Kaplan Krochuk held 6,343 shares of Gilead Sciences worth $884K as of Q1 2026.
Shepherd Kaplan Krochuk sold 93 Gilead Sciences shares in Q1 2026, an estimated $13K.
Gilead Sciences made up 0.74% of Shepherd Kaplan Krochuk's portfolio in Q1 2026, its #35 holding.
Shepherd Kaplan Krochuk first reported a position in Gilead Sciences in Q2 2013 and has held it in 43 quarters since.
Shepherd Kaplan Krochuk's Gilead Sciences position peaked at $1.25M in Q2 2015.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Shepherd Kaplan Krochuk's 13F filing for Q1 2026, filed 15 May 2026.